Literature DB >> 7439169

Cryoenzymic studies on the transition-state analog complex creatine kinase . ADPMg . nitrate . creatine.

F Travers, T E Barman.   

Abstract

Concomitant with the formation of the transition state analog complex creatine kinase . ADPMg . nitrate . creatine [Milner-White, E. J. and Watts, D. C. (1971) Biochem. J. 122, 727--740] there results a large difference spectrum. The shape of the spectrum was characteristic of tryptophan exposure. The kinetics of formation and final amplitude of the spectrum were studied at -15 degrees C using a stopped-flow apparatus. The results obtained allowed for a plausible reaction pathway for nitrate fixation: the ordered addition of nitrate and creatine to the binary enzyme-ADPMg complex, a slow protein isomerization and the final addition of a molecule each of nitrate and creatine. The kinetic parameters for the formation of the transition state analog complex were compared with those already known for the overall reaction obtained under the same conditions [Barman, T. E., Brun, A. and Travers, F. (1980) Dur. J. Biochem. 110, 397--403]. This comparison revealed a striking analogy between the two processes. This suggests that the conformation of creatine kinase in the analog complex is very similar to that in the transition state complex on the catalytic pathway.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439169     DOI: 10.1111/j.1432-1033.1980.tb04881.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Evidence for the two-step binding of ATP to myosin subfragment 1 by the rapid-flow-quench method.

Authors:  T E Barman; D Hillaire; F Travers
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

2.  Cryobaroenzymic studies as a tool for investigating activated complexes: creatine kinase.ADP.Mg.nitrate.creatine as a model.

Authors:  C Balny; F Travers; T Barman; P Douzou
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.